3 of the Best Stocks to Buy for Less Than $100 Right Now

The article highlights three discounted large-caps—Netflix (~$74; ~24x trailing earnings), Pfizer (~$24; ~8x forward P/E with ~7.1% dividend yield), and Verizon (~$42; ~8x forward P/E with ~6.7% dividend yield)—arguing their fundamentals support long-term upside. It cites Netflix revenue of ~$45B last year (+34% vs. two years ago) and strong profitability (about $0.24 of earnings per $1 of revenue), while noting Pfizer has ~20 key studies underway and Verizon’s recent Frontier acquisition to support future growth. Overall, the news is a bullish, valuation-driven pitch rather than a new earnings/guidance catalyst, so likely limited near-term market impact.

Analysis

This is more a factor screen than a catalyst event: it reinforces a market regime where investors pay up for durable cash generation and then search for “cheap” yield elsewhere. The only name with true self-reinforcing economics is NFLX: scale and margin leverage mean incremental demand drops disproportionately to free cash flow, so any weakness is more likely a sentiment mismatch than a business problem. The second-order loser is legacy media/content buyers that need to keep spending to defend share; if NFLX sustains pricing power, the pressure stays on DIS/CMCSA to fund heavier content and product spend.

PFE and VZ are different: both are balance-sheet-and-income stories, not rerating stories. For PFE, the real question is whether pipeline noise can offset looming cash-flow replacement needs; the dividend can anchor the stock for months, but without credible asset-level proof the multiple can remain stranded. For VZ, the issue is not revenue stability but mix and capital intensity: if pricing stays rational, TMUS and even T can continue to take incremental share with better operating leverage, while VZ absorbs integration and network spend.

Contrarian view: the market may be overrewarding “sub-$100” and high yield as if price alone creates upside. NFLX deserves a premium because the earnings power can compound; PFE and VZ likely need specific catalysts, not just valuation, to break out. Over 1-3 months, the key falsifier for the bullish NFLX view is a deceleration in engagement/ARPU conversion; for PFE it is weak pivotal-study data; for VZ it is evidence that Frontier integration fails to improve margin mix or free cash flow.

Key Decisions for Investors

• Long NFLX on pullbacks; pair against DIS or CMCSA over the next 1-3 months to express quality-growth versus legacy-media balance-sheet pressure. Risk/reward improves if NFLX forward multiple stays below high-20s while revenue and operating margin continue to expand.
• Avoid chasing PFE on headline yield alone. Treat it as a watchlist name until the next readout cycle; if pivotal-study updates disappoint, downside can persist despite the 7%+ yield. Falsifier: a clean catalyst package and raised FCF guidance.
• Relative-value short VZ / long TMUS for 6-12 months if telecom pricing remains rational. TMUS retains better operating leverage; VZ’s yield may cap downside, but it is less likely to rerate meaningfully without a margin inflection.
• If you want an income sleeve, prefer PFE over VZ only when you believe dividend coverage is stable and pipeline probability is improving; otherwise, keep the cash in higher-quality defensives with better growth visibility.
• Set an alert on NFLX next earnings implied move: if the market is pricing a muted reaction despite continued margin expansion, consider buying upside calls as a tactical expression of positive surprise.